FDA warning as to memory loss from statins

Scott Pelley on CBS Evening News on 28 Feb. 2012 noted that the FDA had issued new guidelines for a warning label as to memory loss issues from statins (such as Zocor and Lipitor).

See previous IPBiz
Do statins cause transient global amnesia?

From the AP story titled FDA adds new safety information to statin drugs : New labeling on all such drugs will warn of memory loss and confusion reported among certain patients taking statins. In general the problems were not serious and went away after patients stopped taking the drugs, according to the FDA.
The updated labels will also mention elevated levels of blood sugar, associated with diabetes, that have been reported in some patients taking statins. A growing number of studies published over the last five years have found a link between statin use and type 2 diabetes. Last June, a report in the Journal of the American Medical Association analyzed five older randomized trials and concluded the increased risk was small but real for people taking higher doses of any statin.

See also FDA: New Warning Labels for Statins